APNHY
Price
$6.99
Change
+$0.22 (+3.25%)
Updated
Jul 3 closing price
Capitalization
4.83B
ESALF
Price
$29.31
Change
-$0.00 (-0.00%)
Updated
Jun 16 closing price
Capitalization
18.29B
Interact to see
Advertisement

APNHY vs ESALF

Header iconAPNHY vs ESALF Comparison
Open Charts APNHY vs ESALFBanner chart's image
Aspen Pharmacare Holdings
Price$6.99
Change+$0.22 (+3.25%)
Volume$122
Capitalization4.83B
Eisai
Price$29.31
Change-$0.00 (-0.00%)
Volume$1.53K
Capitalization18.29B
APNHY vs ESALF Comparison Chart in %
Loading...
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APNHY vs. ESALF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHY is a Hold and ESALF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (APNHY: $6.99 vs. ESALF: $29.31)
Brand notoriety: APNHY and ESALF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: APNHY: 3% vs. ESALF: 181%
Market capitalization -- APNHY: $4.83B vs. ESALF: $18.29B
APNHY [@Pharmaceuticals: Other] is valued at $4.83B. ESALF’s [@Pharmaceuticals: Other] market capitalization is $18.29B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHY’s FA Score shows that 1 FA rating(s) are green whileESALF’s FA Score has 2 green FA rating(s).

  • APNHY’s FA Score: 1 green, 4 red.
  • ESALF’s FA Score: 2 green, 3 red.
According to our system of comparison, ESALF is a better buy in the long-term than APNHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APNHY’s TA Score shows that 5 TA indicator(s) are bullish while ESALF’s TA Score has 7 bullish TA indicator(s).

  • APNHY’s TA Score: 5 bullish, 2 bearish.
  • ESALF’s TA Score: 7 bullish, 1 bearish.
According to our system of comparison, ESALF is a better buy in the short-term than APNHY.

Price Growth

APNHY (@Pharmaceuticals: Other) experienced а +7.56% price change this week, while ESALF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

APNHY is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESALF($18.3B) has a higher market cap than APNHY($4.83B). ESALF has higher P/E ratio than APNHY: ESALF (46.30) vs APNHY (14.73). ESALF YTD gains are higher at: 14.101 vs. APNHY (-15.357). ESALF has higher annual earnings (EBITDA): 87.3B vs. APNHY (7.98B). ESALF has more cash in the bank: 268B vs. APNHY (8.05B). APNHY has less debt than ESALF: APNHY (26.8B) vs ESALF (126B). ESALF has higher revenues than APNHY: ESALF (744B) vs APNHY (38.4B).
APNHYESALFAPNHY / ESALF
Capitalization4.83B18.3B26%
EBITDA7.98B87.3B9%
Gain YTD-15.35714.101-109%
P/E Ratio14.7346.3032%
Revenue38.4B744B5%
Total Cash8.05B268B3%
Total Debt26.8B126B21%
FUNDAMENTALS RATINGS
APNHY vs ESALF: Fundamental Ratings
APNHY
ESALF
OUTLOOK RATING
1..100
9239
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1006
PRICE GROWTH RATING
1..100
8454
P/E GROWTH RATING
1..100
9393
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESALF's Valuation (13) in the null industry is in the same range as APNHY (16). This means that ESALF’s stock grew similarly to APNHY’s over the last 12 months.

ESALF's Profit vs Risk Rating (100) in the null industry is in the same range as APNHY (100). This means that ESALF’s stock grew similarly to APNHY’s over the last 12 months.

ESALF's SMR Rating (6) in the null industry is significantly better than the same rating for APNHY (100). This means that ESALF’s stock grew significantly faster than APNHY’s over the last 12 months.

ESALF's Price Growth Rating (54) in the null industry is in the same range as APNHY (84). This means that ESALF’s stock grew similarly to APNHY’s over the last 12 months.

ESALF's P/E Growth Rating (93) in the null industry is in the same range as APNHY (93). This means that ESALF’s stock grew similarly to APNHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APNHYESALF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
46%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
43%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
45%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
46%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
PERL.X0.0003480.000014
+4.13%
PERL.eco cryptocurrency
ACH.X0.0190130.000320
+1.71%
Alchemy Pay cryptocurrency
DENT.X0.000616-0.000002
-0.35%
Dent cryptocurrency
NKN.X0.024138-0.000721
-2.90%
NKN cryptocurrency
SEI.X0.271890-0.010432
-3.70%
Sei cryptocurrency

APNHY and

Correlation & Price change

A.I.dvisor tells us that APNHY and TRUFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APNHY and TRUFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHY
1D Price
Change %
APNHY100%
+3.27%
TRUFF - APNHY
21%
Poorly correlated
+13.95%
PRFX - APNHY
20%
Poorly correlated
N/A
ESALF - APNHY
20%
Poorly correlated
N/A
SDZNY - APNHY
20%
Poorly correlated
+0.22%
BIOVF - APNHY
19%
Poorly correlated
N/A
More

ESALF and

Correlation & Price change

A.I.dvisor tells us that ESALF and ESAIY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESALF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESALF
1D Price
Change %
ESALF100%
N/A
ESAIY - ESALF
26%
Poorly correlated
+0.28%
DVAX - ESALF
23%
Poorly correlated
+1.08%
KHTRF - ESALF
22%
Poorly correlated
+4.50%
SHPH - ESALF
22%
Poorly correlated
-1.51%
BLMH - ESALF
21%
Poorly correlated
+1.89%
More